Peter Brechlin

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

Brit Mollenhauer, Claudia Trenkwalder, Nicolas von Ahsen et al. · Dementia and Geriatric Cognitive Disorders · 2006 · 128 citations

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Petra Steinacker, Brit Mollenhauer, Mirko Bibl et al. · Neuroscience Letters · 2004 · 88 citations

Metabolic Syndrome, Neurodegenerative Diseases, Alzheimer's Disease +11

Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies

Brit Mollenhauer, Petra Steinacker, Erik Bahn et al. · Neurodegenerative Diseases · 2007 · 80 citations · Full text

Cerebrospinal fluid‐optimized two‐dimensional difference gel electrophoresis (2‐D DIGE) facilitates the differential diagnosis of Creutzfeldt–Jakob disease

Peter Brechlin, Olaf Jahn, Petra Steinacker et al. · PROTEOMICS · 2008 · 71 citations · Full text

CSF diagnosis of Alzheimer’s disease and dementia with Lewy bodies

Mirko Bibl, Brit Mollenhauer, Hermann Esselmann et al. · Journal of Neural Transmission · 2006 · 67 citations

Neurodegenerative Diseases, Alzheimer's Disease, Dementia +9